Posted by Staff
Apr 30, 2024
Apr 29, 2024
A Chat with Baxter’s President of Front Line Care: Part 1
Abbott Dissolving Stent Granted Earlier-Than-Expected FDA Approval
Philip Closes Out Recall Saga in the US
Labcorp On the Verge of Acquiring Invitae’s Assets